CS

Chromisa Scientific

BE0754.910.220

Gross margin
€ -10K ↑ 79% 2025 Total € 78K
Profit
€ -26K ↑ 59% 2025 Total € -11K
EBITDA
€ -10K ↑ 77% 2025 Total € 76K
EBIT
€ -20K ↑ 65% 2025 Total € 35K
Net profit
€ -26K ↑ 59% 2025 Total € -11K
Capex
€ 0 2025 Total € 4K
Assets
€ 101K ↓ 27% 2025
Equity
€ 18K ↓ 59% 2025
Debt
€ 83K ↓ 12% 2025
Cash
€ 37K ↓ 38% 2025
Cashflow
€ -16K ↑ 69% 2025 Total € 30K
Working capital
€ 15K ↓ 53% 2025
Current ratio
1.18 ↓ 11% 2025
Quick ratio
1.34 ↓ 11% 2025
Working capital ratio
1.25 ↓ 11% 2025
Debt
€ 83K ↓ 12% 2025
Short-term debt
€ 78K ↓ 12% 2025
Long-term debt
€ 12K ↓ 52% 2022
Debt / EBITDA
1.16 ↓ 7% 2022
Solvability
17.7% ↓ 14.1 pt 2025
Long term debt ratio
0.14 ↓ 77% 2022
Gross profitability
-91.8% ↑ 27.6 pt 2025
Net profitability
-145.9% ↓ 2.3 pt 2025
Return On Assets (ROA)
-25.86 ↑ 43% 2025
Return On Equity (ROE)
-146 ↓ 2% 2025
Taxes
€ 1K ↓ 92% 2024 Total € 24K
Dividends
€ 800 2022 Total € 2K
Dividend payout
1.7% ↓ 0.9 pt 2022